Opus Genetics, Inc. — Cash Flow Charts
2 years of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow
$-35M
Free Cash Flow
$-35M
Investing Cash Flow
$0
Financing Cash Flow
$50M
Capex
—
Stock Buybacks
—
Stock-Based Comp
$3M
Debt Issued
—
D&A
$53K
SBC Allocated Expense
$3M
SBC Unrecognized Cost
$6M